Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

South Asian Patients With Diabetic Macular Oedema Treated With Faricimab Assessing the Efficacy, Durability, and Safety (SEAFAR Study)

NCT07753616 is registered in ClinicalTrials.gov with Birmingham and Midland Eye Centre Sandwell and west Birmingham NHS trust as lead sponsor.

NCT NCT07753616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07753616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
South Asian Patients With Diabetic Macular Oedema Treated With Faricimab Assessing the Efficacy, Durability, and Safety (SEAFAR Study)
Lead sponsor
Birmingham and Midland Eye Centre Sandwell and west Birmingham NHS trust
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
November 1, 2029
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema